Yahoo

Chemung Financial (CHMG) Q3 Earnings Signal Stronger Profit Engine

Chemung Financial stock barely flinched after its Q3 2026 report, inching up about 0.6% even as the latest numbers pointed to something more powerful than a routine quarter. Basic earnings per share landed at about US$2.63 on revenue of roughly US$34.6 million, and the trailing net profit margin sits near 31%. For a regional bank, that profitability is the real story. Short term traders saw a quiet day. Longer term investors are likely weighing a business that looks more efficient and still priced below some valuation estimates.

Like Chemung Financial's strong net margin but want a wider pool of efficient regional banks to compare it with? Scan our list of resilient options with solid profitability and cleaner balance sheets in the list of solid balance sheet and fundamentals stocks (25 results) .

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025):US$34.58 million vs. US$27.71 million (up about 25%)

  • Net Income (Q3 2026 vs. Q3 2025):US$12.71 million vs. US$7.68 million (up about 65%)

  • Basic EPS (Q3 2026 vs. Q3 2025):US$2.63 vs. US$1.62 (up about 62%)

  • Net Interest Margin (Q3 2026 trailing vs. Q3 2025 trailing):31% net profit margin vs. 15.5% net profit margin (sharp improvement in profitability)

Ask Charlie what makes Chemung Financial look underpriced .

NasdaqGS:CHMG Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
NasdaqGS:CHMG Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Chemung Financial's margin recovery narrative tested

Belief in Chemung Financial rests heavily on its ability to turn a stronger operating mix into more dependable profit, not just a one quarter pop.

"Management focus on recovering from prior margin pressure, with the aim of translating the materially improved earnings outlook into higher and more stable net income."

The latest quarter backs up that ambition. Net income of US$12.71 million compares with US$7.68 million a year earlier, and basic EPS is higher at US$2.63 versus US$1.62. A trailing net profit margin near 31% versus 15.5% one year ago shows clear progress toward the stability that narrative expects.

Execution risk in Chemung's dual model

The other side of the story questions whether Chemung Financial can keep both banking and wealth operations pulling in the same direction.

"Analyst attention is concentrated on Chemung Financial's combined commercial banking and wealth management model. However, there is limited visibility in this material into how each segment contributes to results, which leaves room for weaker than expected performance in one area to weigh on total revenue and earnings without much early warning for investors."

Current results show consolidated revenue at US$34.58 million and a strong margin, yet no segment breakout. With the stock roughly flat over the past 30 and 90 days, investors appear to be watching for proof that both engines are contributing, not just one.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all .

Hunt Quiet Mispricings Before They Close

Chemung Financial just showed how a stronger margin story does not always move the share price quickly. The real opportunity sits in finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 28% below our estimate - designs liquid cooling and power systems for dense AI data center racks using far less water.

  • Company 2 - 39% below our estimate - expands coconut-based beverages into mainstream grocery while scaling private label production for retailers seeking a ready-made category.

  • Company 3 - 30% below our estimate - supplies offshore vessels that energy producers now contract for longer as constrained fleets increase negotiating leverage on day rates.

Those are three of them. See the full list of 27 companies trading below our fair value estimates →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CHMG .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: